A Phase 1/2, Open-label, Dose Escalation and Expansion Study to Evaluate the Safety and Tolerability of LBS-007 in Patients with Relapsed or Resistant Acute Leukaemias

  • Fleming, Shaun (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date2/06/23 → 2/06/25

Keywords

  • clinical trial
  • leukaemia
  • relapse prevention
  • Metastatic Cancer